tiprankstipranks
Trending News
More News >
Toubujyuhan Co., Ltd. (JP:3297)
:3297
Japanese Market
Advertisement

Toubujyuhan Co., Ltd. (3297) AI Stock Analysis

Compare
0 Followers

Top Page

JP:3297

Toubujyuhan Co., Ltd.

(3297)

Rating:79Outperform
Price Target:
¥1,285.00
▲(12.92% Upside)
The overall stock score of 79 reflects strong financial performance and attractive valuation metrics. The company's robust cash flow and favorable debt management enhance its financial stability. Technical indicators suggest positive momentum, although caution is advised due to overbought signals. The absence of recent earnings call data or notable corporate events means these factors did not influence the score.

Toubujyuhan Co., Ltd. (3297) vs. iShares MSCI Japan ETF (EWJ)

Toubujyuhan Co., Ltd. Business Overview & Revenue Model

Company DescriptionToubujyuhan Co., Ltd. (3297) is a prominent Japanese company engaged in the manufacturing and distribution of high-quality food products, with a strong focus on health-oriented and functional ingredients. The company operates primarily in the food and beverage sector, offering a diverse range of items including processed foods, health supplements, and organic products that cater to both domestic and international markets. Toubujyuhan is committed to innovation and sustainability, leveraging advanced technology in food processing to enhance product quality and meet evolving consumer demands.
How the Company Makes MoneyToubujyuhan Co., Ltd. generates revenue through multiple streams, primarily from the sale of its food products, including processed foods and health supplements. The company capitalizes on the growing consumer trend towards health and wellness by providing functional foods that align with these preferences. Key revenue streams include direct sales through retail partnerships, online platforms, and exports to international markets. Additionally, Toubujyuhan often collaborates with other companies in the food sector to develop co-branded products, which further enhances its market reach and profitability. The company also invests in research and development to innovate new products, ensuring a steady flow of offerings that appeal to health-conscious consumers.

Toubujyuhan Co., Ltd. Financial Statement Overview

Summary
Toubujyuhan Co., Ltd. exhibits a solid financial performance with consistent revenue growth and strong cash flow generation. The balance sheet is robust, with a healthy equity position and manageable debt levels. While profitability margins could be improved, the overall financial health is commendable, positioning the company well for future growth.
Income Statement
75
Positive
The company has shown a consistent revenue growth trend, with a notable increase in the latest year. Gross profit margin and net profit margin have remained stable, indicating efficient cost management. However, there is room for improvement in EBIT and EBITDA margins to enhance profitability further.
Balance Sheet
70
Positive
The balance sheet reflects a strong equity position with a favorable debt-to-equity ratio, indicating prudent financial management. Return on equity is healthy, showcasing effective utilization of shareholder funds. However, the equity ratio suggests a moderate reliance on debt, which could pose risks if not managed carefully.
Cash Flow
80
Positive
The company has demonstrated a significant improvement in operating and free cash flows, with a remarkable free cash flow growth rate. The operating cash flow to net income ratio indicates strong cash generation relative to earnings, enhancing financial flexibility.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue8.03B8.19B7.26B7.67B7.48B7.75B
Gross Profit2.15B2.24B2.01B2.20B2.23B2.18B
EBITDA453.31M555.60M349.59M587.42M603.13M628.75M
Net Income282.88M343.14M212.89M376.83M387.55M391.56M
Balance Sheet
Total Assets6.26B6.14B6.29B5.67B5.37B5.16B
Cash, Cash Equivalents and Short-Term Investments805.32M1.16B891.58M871.69M883.78M1.14B
Total Debt1.40B868.66M1.53B923.72M930.45M985.14M
Total Liabilities2.02B1.71B2.10B1.59B1.60B1.70B
Stockholders Equity4.24B4.43B4.19B4.07B3.76B3.46B
Cash Flow
Free Cash Flow0.001.03B-491.23M86.63M-132.05M1.29B
Operating Cash Flow0.001.05B-388.81M97.69M-59.57M1.47B
Investing Cash Flow0.00-21.64M-101.46M-11.49M-66.95M-192.01M
Financing Cash Flow0.00-771.02M510.16M-98.30M-138.23M-847.48M

Toubujyuhan Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price1138.00
Price Trends
50DMA
1097.54
Positive
100DMA
1129.22
Positive
200DMA
1114.53
Positive
Market Momentum
MACD
9.27
Negative
RSI
70.12
Negative
STOCH
74.76
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3297, the sentiment is Positive. The current price of 1138 is above the 20-day moving average (MA) of 1118.90, above the 50-day MA of 1097.54, and above the 200-day MA of 1114.53, indicating a bullish trend. The MACD of 9.27 indicates Negative momentum. The RSI at 70.12 is Negative, neither overbought nor oversold. The STOCH value of 74.76 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3297.

Toubujyuhan Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (53)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
¥3.04B8.93
3.43%12.69%61.19%
79
Outperform
¥3.98B5.04
1.03%16.28%146.48%
69
Neutral
¥4.02B13.91
1.01%46.64%137.70%
66
Neutral
¥3.54B6.94
0.57%16.67%69.36%
60
Neutral
¥3.74B288.04
9.80%
60
Neutral
¥2.37B22.71
1.89%6.32%-10.34%
53
Neutral
$1.24B3.03-6.08%5.65%-8.21%-81.31%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:3297
Toubujyuhan Co., Ltd.
1,138.00
110.58
10.76%
JP:3490
AZ Planning Co., Ltd.
2,908.00
733.60
33.74%
JP:3494
Mullion Co., Ltd.
513.00
99.26
23.99%
JP:8836
RISE Inc.
39.00
19.00
95.00%
JP:8912
Area Quest Inc.
158.00
17.33
12.32%
JP:8996
HouseFreedom Co., Ltd.
877.00
124.37
16.52%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 29, 2025